A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers Applicability of a novel insulin-independent treatment

Overview of attention for article published in Diabetes Care, June 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy: 2 policy sources

patent: 4 patents

Citations

dimensions_citation: 326 Dimensions

Readers on

mendeley: 133 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Compositions comprising urolithins and uses thereof for the stimulation of insulin…

Grant US-11213508-B2

United States of America

COMBINATION OF SGLT2 INHIBITOR AND A SUGAR COMPOUND FOR THE TREATMENT OF DIABETES

Application WO-2012041898-A1

World Intellectual Property Organisation (WIPO)

Biomarkers for insulin sensitizer drug response

Application US-20110118134-A1

United States of America

METHODS FOR TREATING TYPE 2 DIABETES IN PATIENTS RESISTANT TO PREVIOUS TREATMENT WITH…

Application WO-2010138535-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.